Danone recently adjusted its “specialized nutrition” business in the Chinese market, aiming to integrate existing resources and channels to better leverage its strengths in adult medical nutrition and early-life nutrition.

This adjustment involves Danone’s largest business segment in China, including transferring the pediatric medical nutrition business—previously under the medical nutrition division—to the infant formula division for unified management. Meanwhile, Danone’s adult medical nutrition business welcomed a new leader, Jiang Yifei, who was formerly a vice president at Eli Lilly China. His pharmaceutical background aligns closely with Danone’s adult medical nutrition operations.

This adjustment aligns with Danone’s global strategy, which seeks to rebalance its specialized nutrition business, shifting from a primary focus on infant formula to a dual emphasis on infant formula and medical nutrition. Danone CEO Antoine de Saint-Affrique stated that medical nutrition represents one of the company’s greatest long-term growth opportunities, with the market expected to see significant expansion in the coming years due to factors such as population aging. Danone aims to enhance its competitiveness in the Chinese market by integrating resources, adapting to China’s trend of “moderate aging,” and providing higher-quality products and services to patients and consumers.

2

打赏

表情 点击这里取消回复。